These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11454507)

  • 21. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.
    Lacroix L; Mian C; Caillou B; Talbot M; Filetti S; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2001 Mar; 144(3):297-302. PubMed ID: 11248751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.
    Presta I; Arturi F; Ferretti E; Mattei T; Scarpelli D; Tosi E; Scipioni A; Celano M; Gulino A; Filetti S; Russo D
    BMC Cancer; 2005 Jul; 5():80. PubMed ID: 16029487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.
    Tanaka K; Otsuki T; Sonoo H; Yamamoto Y; Udagawa K; Kunisue H; Arime I; Yamamoto S; Kurebayashi J; Shimozuma K
    Eur J Endocrinol; 2000 Apr; 142(4):340-6. PubMed ID: 10754474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells.
    Bidart JM; Lacroix L; Evain-Brion D; Caillou B; Lazar V; Frydman R; Bellet D; Filetti S; Schlumberger M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4367-72. PubMed ID: 11095481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of iodine metabolism genes in human thyroid tissues: evidence for age and BRAFV600E mutation dependency.
    Espadinha C; Santos JR; Sobrinho LG; Bugalho MJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):629-35. PubMed ID: 18710471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter.
    Russo D; Bulotta S; Bruno R; Arturi F; Giannasio P; Derwahl M; Bidart JM; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Nov; 145(5):591-7. PubMed ID: 11720877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
    Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
    Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?
    Chiefari E; Brunetti A; Arturi F; Bidart JM; Russo D; Schlumberger M; Filetti S
    BMC Cancer; 2002 Dec; 2():35. PubMed ID: 12475396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of sodium iodide symporter expression in differentiated thyroid carcinomas.
    Morari EC; Marcello MA; Guilhen AC; Cunha LL; Latuff P; Soares FA; Vassallo J; Ward LS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):247-54. PubMed ID: 21521301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of thyrotropin receptor gene suggests a high-risk subgroup for oncocytic adenoma.
    Mirebeau-Prunier D; Guyétant S; Rodien P; Franc B; Baris O; Rohmer V; Reynier P; Tourmen Y; Malthièry Y; Savagner F
    Eur J Endocrinol; 2004 Mar; 150(3):269-76. PubMed ID: 15012610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells.
    Passon N; Puppin C; Lavarone E; Bregant E; Franzoni A; Hershman JM; Fenton MS; D'Agostino M; Durante C; Russo D; Filetti S; Damante G
    Thyroid; 2012 May; 22(5):487-93. PubMed ID: 22510021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake.
    Mian C; Barollo S; Pennelli G; Pavan N; Rugge M; Pelizzo MR; Mazzarotto R; Casara D; Nacamulli D; Mantero F; Opocher G; Busnardo B; Girelli ME
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):108-16. PubMed ID: 17854396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
    Carvalho DP; Ferreira AC
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodide symporter gene expression in normal and transformed rat thyroid cells.
    Trapasso F; Iuliano R; Chiefari E; Arturi F; Stella A; Filetti S; Fusco A; Russo D
    Eur J Endocrinol; 1999 May; 140(5):447-51. PubMed ID: 10229912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.
    Pallante P; Federico A; Berlingieri MT; Bianco M; Ferraro A; Forzati F; Iaccarino A; Russo M; Pierantoni GM; Leone V; Sacchetti S; Troncone G; Santoro M; Fusco A
    Cancer Res; 2008 Aug; 68(16):6770-8. PubMed ID: 18701502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.